Follow
Syed Mohd Danish Rizvi
Syed Mohd Danish Rizvi
Assistant Professor, Department of Pharmacy & Toxicology, University of Hail, Hail, K.S.A.
Verified email at uoh.edu.sa
Title
Cited by
Cited by
Year
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal
Saudi journal of biological sciences 22 (1), 90-101, 2015
7362015
A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians
SMD Rizvi, S Shakil, M Haneef
EXCLI journal 12, 831, 2013
2092013
Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance
S Shaikh, N Nazam, SMD Rizvi, K Ahmad, MH Baig, EJ Lee, I Choi
International journal of molecular sciences 20 (10), 2468, 2019
1732019
Silver nanoparticles from leaf extract of Mentha piperita: eco-friendly synthesis and effect on acetylcholinesterase activity
A Khatoon, F Khan, N Ahmad, S Shaikh, SMD Rizvi, S Shakil, ...
Life sciences 209, 430-434, 2018
552018
Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital
S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal
Saudi journal of biological sciences 22 (1), 62-64, 2015
522015
Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals
S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal
Saudi Journal of Biological Sciences 22 (1), 37-41, 2015
492015
Current acetylcholinesterase-inhibitors: A neuroinformatics perspective
S Shaikh, A Verma, S Siddiqui, S S Ahmad, S MD Rizvi, S Shakil, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
442014
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders
S Shaikh, SMD Rizvi, S Shakil, S Riyaz, D Biswas, R Jahan
Biotechnology and applied biochemistry 63 (1), 145-150, 2016
412016
Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer’s disease-diabetes type 2 linkage via an …
S MD Rizvi, S Shakil, D Biswas, S Shakil, S Shaikh, P Bagga, M A Kamal
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
392014
A novel process for size controlled biosynthesis of gold nanoparticles using bromelain
S Khan, SMD Rizvi, M Avaish, M Arshad, P Bagga, MS Khan
Materials Letters 159, 373-376, 2015
362015
Synthesis and Characterization of Cefotaxime Conjugated Gold Nanoparticles and Their Use to Target Drug‐Resistant CTX‐M‐Producing Bacterial Pathogens
S Shaikh, SMD Rizvi, S Shakil, T Hussain, TM Alshammari, W Ahmad, ...
Journal of Cellular Biochemistry 118 (9), 2802-2808, 2017
332017
Multiple targets for the management of Alzheimer’s disease
S Sayeed Ahmad, S Akhtar, Q Mohammad Sajid Jamal, M A Kamal, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016
322016
Isolation, partial purification and evaluation of bioactive compounds from leaves of Ageratum houstonianum
M Zeeshan, SMD Rizvi, MS Khan, A Kumar
Excli Journal 11, 78, 2012
312012
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease
SMD Rizvi, S Shaikh, SMA Waseem, S Shakil, AM Abuzenadah, D Biswas, ...
EXCLI journal 14, 684, 2015
272015
In-vitro antibacterial and antioxidant potential of leaf and flower extracts of Vernonia cinerea and their phytochemical constituents
SM Danish Rizvi, D Biswas, JM Arif, M Zeeshan
Int J Pharm Sci Rev Res 9, 164-169, 2011
272011
Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans
SMD Rizvi, T Hussain, ABF Ahmed, TM Alshammari, A Moin, MQ Ahmed, ...
Biomedicine & Pharmacotherapy 107, 7-18, 2018
222018
Pulmonary targeting of inhalable moxifloxacin microspheres for effective management of tuberculosis
B Vishwa, A Moin, DV Gowda, S Rizvi, WAH Hegazy, AS Abu Lila, ...
Pharmaceutics 13 (1), 79, 2021
212021
Kinetics and molecular docking study of an anti-diabetic drug glimepiride as acetylcholinesterase inhibitor: implication for Alzheimer’s disease-diabetes dual therapy
SM Rizvi, S Shaikh, D Naaz, S Shakil, A Ahmad, M Haneef, ...
Neurochemical research 41 (6), 1475-1482, 2016
212016
Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: An enzoinformatics approach
A Alam, S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
212014
Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a …
S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
192014
The system can't perform the operation now. Try again later.
Articles 1–20